Companies that own Geron Corp.
SSgA Funds Management, Inc.
15,506,128
8.44%
9,279,951
0.01%
06/30/2018
BlackRock Fund Advisors
12,501,219
6.81%
1,384,383
0%
06/30/2018
Fidelity Management & Research Co.
12,045,519
6.56%
-3,518,874
0.01%
07/31/2018
The Vanguard Group, Inc.
7,765,278
4.23%
665,576
0%
06/30/2018
British & American Investment Trust Plc (Invt Mgmt)
2,632,601
1.43%
-505,981
48.76%
12/31/2017
Northern Trust Investments, Inc.
1,985,585
1.08%
186,597
0%
06/30/2018
Geode Capital Management LLC
1,605,106
0.87%
166,698
0%
06/30/2018
New Jersey Division of Investment
1,015,000
0.55%
0
0.02%
06/30/2018
Merrill Lynch, Pierce, Fenner & Smith, Inc. (Invt Mgmt)
729,373
0.4%
472,195
0%
06/30/2018
QS Investors LLC
688,195
0.38%
0
0.03%
06/30/2018
| Address |
149 Commonwealth Drive
Menlo Park California 94025
United States
|
|
Employees
|
- |
| Website |
http://www.geron.com |
| Updated |
07/08/2019 |
| Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The company was founded by Michael D. |
